RC, C., S, H., SR, L., L, K., J, M., Z, M., . . . MG, K. (2023). Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. Nature communications, 14(1), 4741. https://doi.org/10.1038/s41467-023-40561-x
Chicago Style (17th ed.) CitationRC, Coombes, et al. "Author Correction: Dose Escalation and Expansion Cohorts in Patients with Advanced Breast Cancer in a Phase I Study of the CDK7-inhibitor Samuraciclib." Nature Communications 14, no. 1 (2023): 4741. https://doi.org/10.1038/s41467-023-40561-x.
MLA (9th ed.) CitationRC, Coombes, et al. "Author Correction: Dose Escalation and Expansion Cohorts in Patients with Advanced Breast Cancer in a Phase I Study of the CDK7-inhibitor Samuraciclib." Nature Communications, vol. 14, no. 1, 2023, p. 4741, https://doi.org/10.1038/s41467-023-40561-x.